PROFILE/SHEET EXTRUDER R A I L S A N D K I C K P L A T E S • Convert existing PVC profile and sheet rails and kick plates to polyolefin resin to meet Class A fire safety (ASTM E84) • Provide a system that meets healthy building certifications and approvals • Utilize a more sustainable flame retardant technology, removing brominated or halogenated flame retardants from the environment • Achieve non-compromising performance in aesthetics, impact, dimensional stability, CLTE, and E84 testing • Provided broad flame retardant platform, backed by extensive application and industry expertise, to meet global flammability standards • Has largest UL94 recognized Prospector membership with HB, V-0, V-1, V-2 and 5VA/5VB ratings, and broad glow wire performance products • Included in-house UL certified labs and manufacturing locations to perform UL94 material sampling and testing • Supported application development to meet fire safety standards, address current or emerging healthy building codes, smart home requirements, and LEED credits • Offered custom formulations in small lot quantities Cesa™ Flam Non-Halogen Flame Retardants KEY REQUIREMENTS WHY AVIENT?

� 'PliiAPT ih �� � GNAS :::; 1�� ':t '"�� � =�� SYSTEM -si;�-;;db;:·x�-Zh��x� MEMBER OF ••••• ......... .· .•.. •·····--·· . . � IQNET CHINA QUALITY CERTIFICATION CENTRE Section 9, No.188, Nansihuan(the South Fourth Ring Road) Xilu(West Road), Beijing 100070, China http://www.cqc.com.cn A 0082431 20221:f=�&

ECert.QECertificate Page 1 of 2 Validity of this certificate is based on the successful completion of the periodic surveillance audits of the management system defined by the above scope and is contingent upon prompt,written notification to ABS Quality Evaluations, Inc. of significant changes to the management system or components thereof.

1 (3) Pending matter(s) The register indicates pending matter(s) regarding a change to the registered information at the time this certificate was created. 2 (3) Registration number: 516411-5031 Business name: Avient S.à r.l., Sweden Filial Address: Drottninggatan 56 411 07 GÖTEBORG County and municipality: Västra Götaland, Göteborg Note: MANAGING DIRECTOR 630516 Palm, Christoph, Gruss Strooss 35, L-9991 WEISWAMPACH, LUXEMBURG AUDITORS 556053-5873 Ernst & Young Aktiebolag, Box 7850, 103 99 STOCKHOLM Represented by: 850807-5135 PRINCIPALLY RESPONSIBLE AUDITOR 850807-5135 Edman, Mikael Thomas Gunnar, c/o Ernst & Young AB, 401 82 GÖTEBORG SIGNATORY POWER Signatory power alone by Palm, Christoph FINANCIAL YEAR Registered financial year: 0101 - 1231 DATE OF REGISTRATION OF CURRENT AND PREVIOUS BUSINESS NAMES 2021-11-29 Avient S.à r.l., Sweden Filial 2018-08-28 PolyOne S.à.r.l., Sweden Filial INFORMATION ABOUT THE FOREIGN COMPANY B226205 Avient S.á.r.l. 19, Route de Bastogne L-9638 Pommerloch LUXEMBURG Registered office of the foreign company: Pommerloch Name of the register in which the foreign company is registered: 3 (3) RCS, Registre de Commerce, Luxembourg Business Register LUXEMBURG Foreign company's financial year: 0101 - 1231 The above information is an extract from the Trade and Industry Register Bolagsverket, the Swedish Companies Registration Office.

https://www.avient.com/products/engineered-polymer-formulations/conductive-signal-radiation-shielding-formulations/stat-tech-static-dissipative-electrically-conductive-formulations Slide 1: Semiconductor packaging OEM

One caveat: Typical TPE shrinkage is around 2% while that of substrate materials is closer to 1%. When looking to incorporate sustainable content into your TPE, the raw material cost may be more expensive than traditional materials for three reasons 1) supply chain maturity, 2) high demand, low supply, 3) location of source and supplier. http://www.art.canaco.org https://www.avient.com/sites/default/files/2020-11/gls-acqua-plose-case-study.pdf 1http://store.elsevier.com/Handbook-of-Polymer-Applications-in-Medicine- and-Medical-Devices/isbn-9780323221696/ Tear Resistance In Handbook of Polymer Applications in Medicine and Medical Devices,1 Laurence W.

主要特性 在三个经ISO 13485认证的生产设施生产，在 全球范围内提供质量稳定一致的产品，并增加 供应稳定性 变更控制记录的级别高于CAS编号级别，降低 变更风险 不含动物源性物质和邻苯二甲酸盐 可用作预着色配方或母粒，用于不同的聚合物 注册药品管理档案（III类）和/或医疗器械主 文件 食品接触符合FDA/EU**要求 法规支持 原材料根据以下标准检测： - ISO 10993-1和美国药典 生物学 评估 - 欧洲药典3.1.3/3.1.5（聚烯烃） - 美国药典（聚乙烯） - ICH Q3D 杂质元素 * 设计备注：选择效果颜色时需要仔细考虑零件设计和聚合物流动路径， 从而尽可能减少可见流线。 在不限制本声明的一般性的情况下，不得将埃万特的产品用于旨在用于以下目的的任何医疗器械应用： (1) 接触人体组织或体液长达30天或更长时间； (2)“整形”（整容或重建）手术； (3) 生殖植入物或任何节育器械；或者 (4) 用于支持或维持人类生命的永久性（超过30天）植入式医疗器械中的任何关键组件。

Avient は、指定された比誘電率（ Dk）の材料を1週間でサンプル試作することができ、2～3週間で工場スケールで製 造し、出荷することができます。 ベース樹脂 誘電率（Dk） ET7600- 8031 ET7600- 8027 ET7600- 8025 ET7600- 8037 ET7600- 8019 ET7600- 8028 ET7600- 8026 ET7600- 8044 ET7600- 8029 ET7600- 8041 ET7600- 8045 ET7600- 8036 PPE PPE PPE PPE PPE PPE PPE PPE PPE PPE PPE PPE 3.0 3.1 3.35 3.6 3.8 4.4 4.8 5.28 5.4 5.85 7.0 9.0 EDGETEK TM EDGETEK TM Avient のカスタマイズされた材料設計は、5G基地局のアンテナの進化にどのような優位性をもたらすか 素早い仕様決定と、短いリードタイム - PolyOne は１ 週間以内で指定されたDk値でサンプルを試作し、2～3 週間以内に工場スケールで製品をお届けします。

主要特性 在三个通过ISO 13485认证的医疗生产线生 产全球统一的配方，提供全球一致性和供应 链保障 变更控制记录不限于CAS编号级别，降低变 更风险 不含动物源性物质和邻苯二甲酸盐 可用作各种聚合物的母粒或即用型配方 为方便起见，可在一个产品中实现功能性和颜 色的组合 法规支持 经过预测试的原材料： - ISO 10993-1 - USP 第、章（VI类） - USP （指南），6.2.3 可萃取元素； USP - ICHQ3D/USP 2 可萃取金属 - 欧洲药典 3.1 聚烯烃（如适用） FDA发布的注册药品主文件（III类）和/或医疗 器械主文件 为符合（新）法规（如IVDR）的批准或过渡提 供文档支持 适用医疗保健使用限制—见下文。 在不限制本声明的一般性的情况下，不得将埃万特的产品用于旨在用于以下目的的任何医疗器械应用： (1) 接触人体组织或体液长达30天或更长时间； (2)“整形”（整容或重建）手术； (3) 生殖植入物或任何节育器械；或者 (4) 用于支持或维持人类生命的永久性（超过30天）植入式医疗器械中的任何关键组件。

KEY CHARACTERISTICS • Manufactured at four ISO 13485 certified sites, providing global consistency and increased security of supply • Documented change control beyond CAS number, reducing risk of change • Available as additive concentrates, ready-to-use additive formulations or ready-to-use additive/ colorant formulations for different polymers REGULATORY SUPPORT • Raw materials tested to: - ISO 10993-1 and USP biological evaluation - European Pharmacopeia 3.1.3/3.1.5 (polyolefin) - USP (polyethylene) - ICH Q3D elemental impurities • Registered Drug Master File (Type III) and/or Device Master File • Food contact established with FDA/EU* APPLICATION BULLETIN * FDA/EU compliance information available upon request; exceptions may occur Healthcare use limitations apply—see below.